There never seems to be a bad time for Cathie Wood to reshape her portfolios. The founder, CEO, and main stock-picker for the Ark Invest family of exchange-traded funds has been busy adding to some of her positions this week. She has also been pruning some of her holdings, but let's talk about the buys.

Wood added to existing positions in Meta Platforms (NASDAQ: META), Recursion Pharmaceuticals (NASDAQ: RXRX), and Ginkgo Bioworks (NYSE: DNA) this week. Let's take a closer look.

One of last year's biggest winners was Facebook parent Meta Platforms. The stock nearly tripled last year, up 194%. I know I wasn't the only investor who shook my head when Facebook changed its corporate moniker to Meta in the fall of 2021. I guess CEO Mark Zuckerberg is getting the last laugh now.

Continue reading

Source Fool.com